Indevus Pharmaceuticals Inc.

(NASDAQ:IDEV)

Key Stats & Ratios

Valuation
Market Cap 420.46M
P/E
P/E (Trailing) -6.15
P/E (Forward)
Price/Sales 3.15
Price/Book
EPS -0.86
EPS Growth (ttm)
Fiscal Year
Fiscal Year Ends Sep 30
Last Quarter Jun 2008
Profitability
Operating Income -59110000.00
Net Income -65551000.00
Profit Margin (ttm) -84.30%
Operating Margin (ttm) -0.75%
Management Effectiveness
Return on Assets (ttm) -24.90%
Return on Equity (ttm)
EBIT Margin (ttm) -72.80
Memberships
Russel 2000
SEC Filings
Latest Form 10-Q (Quartely)
Latest Form 10-K (Annual)

Financials

Income Statement
Total Enterprise Value 219.87M
Revenue 77.79M
Revenue/Share 1.00
Revenue Growth (ytd) 17.70%
Annual Revenue Growth Rate (3Y) 32.46%
Annual Income Growth Rate (3Y)
Earnings Growth (ytd)
Gross Operating Profit (ttm) 51.76M
EBITDA -49054000.00
Diluted EPS (ttm) -0.86
Balance Sheet
Total Cash 131.29M
Total Cash/Share 1.68
Total Assets 263.00M
Total Liabilities 393.19M
Total Debt/Equity
Long Term Debt Common Equity Ratio
Current Ratio 1.00
Leverage Ratio
Book Value/Share
Cash Flow
Cash Flow -58475000.00
Free Cash Flow -33685000.00
Cash Flow/Share -0.75
Free Cash Flow/Share -0.43

Trading Information

Stock Price History
Beta
52Wk Change -13.50%
52Wk Change Vs. Mkt 30.00%
52Wk High 6.95
52Wk Low 1.19
10 Day Moving Average 3.15
200 Day Moving Average 2.78
Share Statistics
Average Volume 2.64M
Shares Outstanding 78.15M
Shares Float 77.37M
% Held by Insiders 1.00%
% Held by Institutions 55.20%
Shares Short (As of Dec 10, 2008) 7.90M
Short Ratio 15.20
Short % of Float 10.20%
Dividends & Splits
Dividend Date
Dividend Yield
Dividend Amount